You are here

Article Text

Article menu
Download PDFPDF
Articles
New fluoroquinolone antibiotics

  • Relevant BNF section: 5.1.12

Abstract

In 1993, we reviewed three fluoroquinolone antibiotics (ciprofloxacin, norfloxacin and ofloxacin).1 Since then, four more fluoroquinolones have been awarded marketing authorisations. Here we review the clinical evidence and discuss the place of two of these drugs, ▼grepafloxacin (Raxar - GlaxoWellcome) and ▼levofloxacin (Tavanic - Hoechst Marion Roussel). Sparfloxacin and trovafloxacin are not considered, as they are not yet commercially available.

https://doi.org/10.1136/dtb.1999.3716

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.